Trademark: 88230399
Word
NEW-LEA
Status
Dead
Status Code
606
Status Date
Monday, May 23, 2022
Serial Number
88230399
Mark Type
4000
Filing Date
Friday, December 14, 2018
Published for Opposition
Tuesday, February 19, 2019
Abandoned Date
Monday, May 23, 2022

Trademark Owner History
Regeneron Pharmaceuticals, Inc. - Owner At Publication

Classifications
44 Providing educational information regarding ophthalmic diseases and pharmaceutical preparations for the treatment of ophthalmic diseases

Trademark Events
May 23, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
May 23, 2022
Abandonment - No Use Statement Filed
Sep 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 22, 2021
Sou Extension 5 Granted
Sep 17, 2021
Sou Extension 5 Filed
Sep 22, 2021
Case Assigned To Intent To Use Paralegal
Sep 17, 2021
Sou Teas Extension Received
Mar 17, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 15, 2021
Sou Extension 4 Granted
Mar 15, 2021
Sou Extension 4 Filed
Mar 15, 2021
Sou Teas Extension Received
Sep 23, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 21, 2020
Sou Extension 3 Granted
Sep 21, 2020
Sou Extension 3 Filed
Sep 21, 2020
Sou Teas Extension Received
Mar 31, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 27, 2020
Sou Extension 2 Granted
Mar 27, 2020
Sou Extension 2 Filed
Mar 27, 2020
Sou Teas Extension Received
Oct 15, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 11, 2019
Sou Extension 1 Granted
Oct 11, 2019
Sou Extension 1 Filed
Oct 11, 2019
Sou Teas Extension Received
Apr 16, 2019
Noa E-Mailed - Sou Required From Applicant
Feb 19, 2019
Official Gazette Publication Confirmation E-Mailed
Feb 19, 2019
Published For Opposition
Jan 30, 2019
Notification Of Notice Of Publication E-Mailed
Jan 8, 2019
Approved For Pub - Principal Register
Jan 8, 2019
Assigned To Examiner
Jan 7, 2019
New Application Office Supplied Data Entered
Dec 18, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24